These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6488712)

  • 21. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
    Riggs BL
    Endocrinol Jpn; 1979 Jun; 26(Suppl):31-41. PubMed ID: 467347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age and menopause-related changes in indices of bone turnover.
    Kelly PJ; Pocock NA; Sambrook PN; Eisman JA
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1160-5. PubMed ID: 2511220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.
    Duda RJ; Kumar R; Nelson KI; Zinsmeister AR; Mann KG; Riggs BL
    J Clin Invest; 1987 Apr; 79(4):1249-53. PubMed ID: 3494046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of salt restriction on urine hydroxyproline excretion in postmenopausal women.
    Need AG; Morris HA; Cleghorn DB; De Nichilo D; Horowitz M; Nordin BE
    Arch Intern Med; 1991 Apr; 151(4):757-9. PubMed ID: 2012460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyproline peptides and bone mass in postmenopausal and osteoporotic women.
    Aloia JF; Cohn SH; Zanzi I; Abesamis C; Ellis K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):314-8. PubMed ID: 263298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
    Tsai KS; Ebeling PR; Riggs BL
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
    Need AG; Philcox JC; Hartley TF; Nordin BE
    Aust N Z J Med; 1986 Jun; 16(3):341-6. PubMed ID: 3465310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
    Esedova AE; Gadzhieva MM; Ferzilaeva RA
    Klin Lab Diagn; 2002 Mar; (3):13-6. PubMed ID: 11980136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
    Celik E; Guzel S; Abali R; Guzelant AY; Celik Guzel E; Kuçukyalcin V
    Minerva Med; 2013 Oct; 104(5):497-504. PubMed ID: 24101107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preliminary results of endocrine investigations in postmenopausal osteoporosis (author's transl)].
    Franchimont P; Heynen G; Reginster M; Denis F
    J Belge Rhumatol Med Phys; 1973 Sep; 28(5):353-62. PubMed ID: 4211093
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.
    Riggs B; Jowsey J; Kelly PJ; Arnaud CD
    Boll Soc Ital Biol Sper; 1973 Jul; 49(12):732-7. PubMed ID: 4364781
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for postmenopausal osteoporosis.
    Aloia JF; Cohn SH; Vaswani A; Yeh JK; Yuen K; Ellis K
    Am J Med; 1985 Jan; 78(1):95-100. PubMed ID: 3966495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.